Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.

Cox MC, Castiello L, Mattei M, Santodonato L, D'Agostino G, Muraro E, Martorelli D, Lapenta C, Di Napoli A, Di Landro F, Cangemi M, Pavan A, Castaldo P, Hohaus S, Donati S, Montefiore E, Berdini C, Carlei D, Monque DM, Ruco L, Prosperi D, Tafuri A, Spadaro F, Sestili P, Spada M, Dolcetti R, Santini SM, Rozera C, Aricò E, Capone I, Belardelli F.

Clin Cancer Res. 2019 Sep 1;25(17):5231-5241. doi: 10.1158/1078-0432.CCR-19-0709. Epub 2019 Jun 6.

PMID:
31171545
2.

Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients.

Cangemi M, Montico B, Faè DA, Steffan A, Dolcetti R.

Front Oncol. 2019 Mar 27;9:160. doi: 10.3389/fonc.2019.00160. eCollection 2019. Review.

3.

Heavy Metal Concentrations in the Groundwater of the Barcellona-Milazzo Plain (Italy): Contributions from Geogenic and Anthropogenic Sources.

Cangemi M, Madonia P, Albano L, Bonfardeci A, Di Figlia MG, Di Martino RMR, Nicolosi M, Favara R.

Int J Environ Res Public Health. 2019 Jan 21;16(2). pii: E285. doi: 10.3390/ijerph16020285.

4.

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.

Muraro E, Merlo A, Martorelli D, Cangemi M, Dalla Santa S, Dolcetti R, Rosato A.

Front Immunol. 2017 Feb 27;8:197. doi: 10.3389/fimmu.2017.00197. eCollection 2017. Review.

5.

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.

Gammaitoni L, Giraudo L, Macagno M, Leuci V, Mesiano G, Rotolo R, Sassi F, Sanlorenzo M, Zaccagna A, Pisacane A, Senetta R, Cangemi M, Cattaneo G, Martin V, Coha V, Gallo S, Pignochino Y, Sapino A, Grignani G, Carnevale-Schianca F, Aglietta M, Sangiolo D.

Clin Cancer Res. 2017 May 1;23(9):2277-2288. doi: 10.1158/1078-0432.CCR-16-1524. Epub 2016 Nov 4.

6.

Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.

Giraudo L, Gammaitoni L, Cangemi M, Rotolo R, Aglietta M, Sangiolo D.

Immunotherapy. 2015;7(9):999-1010. doi: 10.2217/imt.15.61. Epub 2015 Aug 27. Review.

PMID:
26310715
7.

Adoptive immunotherapy against sarcomas.

Mesiano G, Leuci V, Giraudo L, Gammaitoni L, Carnevale Schianca F, Cangemi M, Rotolo R, Capellero S, Pignochino Y, Grignani G, Aglietta M, Sangiolo D.

Expert Opin Biol Ther. 2015 Apr;15(4):517-28. doi: 10.1517/14712598.2015.987121. Epub 2014 Dec 16. Review.

PMID:
25516119
8.

1991 Magadan, USSR/Alaska, USA Dental Exchange Program Report.

Allen RJ, Cangemi MH, Craft CF.

Alaska Med. 1992 Jan-Mar;34(1):59-61.

PMID:
1605343

Supplemental Content

Loading ...
Support Center